Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

How I treat warm autoimmune hemolytic anemia

Wilma Barcellini, Bruno Fattizzo

Blood (2021) 137 (10): 1283–1294.

https://doi.org/10.1182/blood.2019003808

Published: 2021

Journal Articles

FcRn augments induction of tissue factor activity by IgG-containing immune complexes

Douglas B. Cines, Sergei Zaitsev, Lubica Rauova, Ann H. Rux, Victoria Stepanova, Sriram Krishnaswamy, Amrita Sarkar, M. Anna Kowalska, Guohua Zhao, Alan E. Mast, Laurence J. Blumberg, Keith R. McCrae, Mortimer Poncz, Jonathan J. Hubbard, Michal Pyzik, Richard S. Blumberg

Blood (2020) 135 (23): 2085–2093.

https://doi.org/10.1182/blood.2019001133

Published: 2020

Includes: Supplemental data

Journal Articles

Retrospective and Prospective Study of Childhood Autoimmune Hemolytic Anemia. a Preliminary Report from the Red Cell Working Group of the Paediatric Hemato-Oncology Italian Associations (AIEOP)

Blood (2019) 134 (Supplement_1): 947.

https://doi.org/10.1182/blood-2019-124735

Published: 2019

Journal Articles

Trial in Progress: Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Study of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Nichola Cooper, MD MRCP, Isabel Gorham, BS RN, Ann M. Lowe, MD, Robert P. Numerof, PhD, Sandy Tong, MD, David J. Kuter

Blood (2019) 134 (Supplement_1): 4800.

https://doi.org/10.1182/blood-2019-126544

Published: 2019

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Kerry A. Rogers, MD, Michael A. Boxer, MD, Michael Y. Choi, MD, Richy Agajanian, MD, Donald M. Arnold, MD, Catherine M. Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Donna Chow, Robert P. Numerof, PhD, Hanzhe Zheng, PhD, Sandy Tong, MD, David J. Kuter

Blood (2019) 134 (Supplement_1): 3518.

https://doi.org/10.1182/blood-2019-126509

Published: 2019

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

David J. Kuter, MD DPhil, Richy Agajanian, MD, Donald M. Arnold, MD MSc, FRCPC, Michael Boxer, MD, Catherine Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Kerry A. Rogers, MD, Ann M Lowe, MD, Sandra Tong, MD, Hany Zayed, PhD, Anne-Marie Duliege, MD MS

Blood (2018) 132 (Supplement 1): 3612.

https://doi.org/10.1182/blood-2018-99-110483

Published: 2018

Journal Articles

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Autoimmune Hemolytic Anemia (AIHA)

Federico Grossi, MD, Merrill Kingman Shum, MD, Morie A. Gertz, MD, Eloy Roman, MD, Pascal Deschatelets, PhD, Mohamed Hamdani, MS, Frank Stout, Cedric G Francois, MD PhD

Blood (2018) 132 (Supplement 1): 3623.

https://doi.org/10.1182/blood-2018-99-119468

Published: 2018

Journal Articles

An Unusual Case of Autoimmune Hemolytic Anemia-Thinking Outside the Box for Management

Paul C Williams, MD, Ileana Lopez-Plaza, MD

Blood (2018) 132 (Supplement 1): 5075.

https://doi.org/10.1182/blood-2018-99-111196

Published: 2018

Journal Articles

Conservative Management of Idiopathic Hemophagocytic Lymphohistiocytosis (HLH) Achieving Complete Remission

Jesus C Fabregas, MD, Guiset Carvajal, MD

Blood (2018) 132 (Supplement 1): 4963.

https://doi.org/10.1182/blood-2018-99-112029

Published: 2018

Journal Articles

SYNT001: A Humanized IgG4 Monoclonal Antibody That Disrupts the Interaction of FcRn and IgG for the Treatment of IgG-Mediated Autoimmune Diseases

Laurence Blumberg, MD, John E Humphries, MD, Kenneth C Lasseter, MD, Richard S Blumberg, MD

Blood (2017) 130 (Supplement 1): 3483.

https://doi.org/10.1182/blood.V130.Suppl_1.3483.3483

Published: 2017

Journal Articles

Use of Eculizumab in a Patient with Refractory Autoimmune Hemolytic Anemia with Heterozygous NFκB1 Mutation

Katharine Halligan, MD PhD, Lana Vasiljevic, Phillip Roehrs, MD, Andrew Mcginnitie, MD, Sung-Yun Pai, MD, Rachael F. Grace, MD, Maria Olivares Boucher, MD, Lauren Weintraub, MD

Blood (2017) 130 (Supplement 1): 4743.

https://doi.org/10.1182/blood.V130.Suppl_1.4743.4743

Published: 2017

Journal Articles

Can Rituximab be Useful for Treating SLE-Associated Immune Cytopenias ? Results from a Retrospective Multicentre Study on 62 Patients

Alexandra Serris, MD, Zahir Amoura, MD MSc, Benjamin Terrier, MD PhD, Eric Hachulla, MD PhD, Nathalie Costedoat-Chalumeau, MD PhD, Thomas Papo, MD, Olivier Lambotte, MD PhD, David Saadoun, MD PhD, Miguel Hie, MD, Philippe Blanche, Corinne Haioun, MD, Bertrand Lioger, Bertrand Godeau, MD PhD, Marc Michel, MD

Blood (2016) 128 (22): 870.

https://doi.org/10.1182/blood.V128.22.870.870

Published: 2016

Journal Articles

High Incidence of Venous Thromboembolism Events during Warm Autoimmune Hemolytic Anemia

Sylvain Audia, MD PhD, Benoit Bach, MD, Maxime Samson, MD PhD, Vanessa Leguy, MD, Sabine Berthier, MD, Bernard Bonnotte, MD PhD

Blood (2016) 128 (22): 2448.

https://doi.org/10.1182/blood.V128.22.2448.2448

Published: 2016

Journal Articles

BAFF and CD4 T-Cells Are Major Survival Factors for Splenic Plasma Cells in B Cell Depletion Context: Implications for Autoimmune Diseases

Lan-Huong Thai, MD PhDstudent, Ailsa Robbins, Simon Le Gallou, PhD, Nicolas Cagnard, Jean-Claude Weill, Professor, Claude-Agnès Reynaud, PhD, Matthieu Mahevas, MD PhD

Blood (2016) 128 (22): 129.

https://doi.org/10.1182/blood.V128.22.129.129

Published: 2016

Journal Articles

Combination Treatment of Rituximab, Cyclophosphamide, and Dexamethasone for Warm Autoimmune Hemolytic Anemia

Hillel Bocian, MD, Caroline Piatek, MD, Howard A Liebman, MD, Casey L O'Connell, MD, Ilene Ceil Weitz, MD, Cage Saul Johnson, MD

Blood (2016) 128 (22): 4802.

https://doi.org/10.1182/blood.V128.22.4802.4802

Published: 2016

Journal Articles

Bortezomib Yields High Response Rates in Antibody-Mediated Autoimmune Hematological Diseases Refractory to Conventional Immunosuppression

Sumita Ratnasingam, MBBS, Patricia A. Walker, MBBS, Huy Tran, MBBS, Zane Kaplan, MD, James David McFadyen, MD, Huyen Tran, MD, Tse-Chieh Teh, MD, Erica M. Wood, MD, John V. Catalano, MD, Stephen Opat, MBBS, Jake Shortt, MD

Blood (2015) 126 (23): 3457.

https://doi.org/10.1182/blood.V126.23.3457.3457

Published: 2015

Journal Articles

A Multi-Centre Randomized and Double-Blind Controlled Trial of Rituximab for Warm Autoimune Hemolytic Anemia in Adults

Marc Michel, MD, Louis Terriou, MD, Françoise Roudot-Thoraval, MD PhD, Mohamed Hamidou, MD PhD, Mikael Ebbo, MD, Guillaume Le guenno, Sylvain Audia, MD PhD, Bruno Royer, MD, anne-Sophie Morin, MD, Jean Marie Michot, MD, Arnaud Jaccard, MD PhD, Laurent Frenzel, MD PhD, Corinne Haioun, MD PhD, Mehdi Khellaf, MD, Bertrand Godeau, MD PhD

Blood (2015) 126 (23): 3338.

https://doi.org/10.1182/blood.V126.23.3338.3338

Published: 2015

Journal Articles

A Rare Case of Bleeding - Acquired Factor Inhibitors with Normal Coagulation Tests

Harsh Shah, DO, Samantha Armstrong, MD, Naveen Manchanda, MBBS

Blood (2015) 126 (23): 4702.

https://doi.org/10.1182/blood.V126.23.4702.4702

Published: 2015

Journal Articles

Portal or Splenic Vein Thrombosis after Splenectomy for Immune Cytopenia: A Retrospective Cohort Study

Caroline Morbieu, Francesco Brunetti, MD, Laurence Baranès, MD, Laetitia Languille, Nicolas Limal, MD, Valentine Loustau, MD, Philippe Bierling, MD PhD, Marc Michel, MD, Bertrand Godeau, MD PhD, Matthieu Mahévas, MD PhD

Blood (2015) 126 (23): 3483.

https://doi.org/10.1182/blood.V126.23.3483.3483

Published: 2015

Journal Articles

The role of rituximab in adults with warm antibody autoimmune hemolytic anemia

Daan Dierickx, Alain Kentos, André Delannoy

Blood (2015) 125 (21): 3223–3229.

https://doi.org/10.1182/blood-2015-01-588392

Published: 2015

NARROW

How I treat warm autoimmune hemolytic anemia

FcRn augments induction of tissue factor activity by IgG-containing immune complexes

Retrospective and Prospective Study of Childhood Autoimmune Hemolytic Anemia. a Preliminary Report from the Red Cell Working Group of the Paediatric Hemato-Oncology Italian Associations (AIEOP)

Trial in Progress: Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Study of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Autoimmune Hemolytic Anemia (AIHA)

An Unusual Case of Autoimmune Hemolytic Anemia-Thinking Outside the Box for Management

Conservative Management of Idiopathic Hemophagocytic Lymphohistiocytosis (HLH) Achieving Complete Remission

SYNT001: A Humanized IgG4 Monoclonal Antibody That Disrupts the Interaction of FcRn and IgG for the Treatment of IgG-Mediated Autoimmune Diseases

Use of Eculizumab in a Patient with Refractory Autoimmune Hemolytic Anemia with Heterozygous NFκB1 Mutation

Can Rituximab be Useful for Treating SLE-Associated Immune Cytopenias ? Results from a Retrospective Multicentre Study on 62 Patients

High Incidence of Venous Thromboembolism Events during Warm Autoimmune Hemolytic Anemia

BAFF and CD4 T-Cells Are Major Survival Factors for Splenic Plasma Cells in B Cell Depletion Context: Implications for Autoimmune Diseases

Combination Treatment of Rituximab, Cyclophosphamide, and Dexamethasone for Warm Autoimmune Hemolytic Anemia

Bortezomib Yields High Response Rates in Antibody-Mediated Autoimmune Hematological Diseases Refractory to Conventional Immunosuppression

A Multi-Centre Randomized and Double-Blind Controlled Trial of Rituximab for Warm Autoimune Hemolytic Anemia in Adults

A Rare Case of Bleeding - Acquired Factor Inhibitors with Normal Coagulation Tests

Portal or Splenic Vein Thrombosis after Splenectomy for Immune Cytopenia: A Retrospective Cohort Study

The role of rituximab in adults with warm antibody autoimmune hemolytic anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only